...
首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward
【24h】

Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward

机译:多轨道决策分析支持健康技术评估机构:福利,局限性和前进方向

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Recent years have witnessed an increased interest in the use of multicriteria decision analysis (MCDA) to support health technology assessment (HTA) agencies for setting healthcare priorities. However, its implementation to date has been criticized for being "entirely mechanistic," ignoring opportunity costs, and not following best practice guidelines. This article provides guidance on the use of MCDA in this context.
机译:目的:近年来,目睹了利用多铁路决策分析(MCDA)来支持健康技术评估(HTA)机构来制定医疗保健优先事项的兴趣增加。 但是,它的迄今为止的实施被“完全机械师”忽视了机会成本,而不是遵循最佳实践指南。 本文提供了关于在此背景下使用MCDA的指导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号